PUBLICATION
The antidepressant venlafaxine perturbs cardiac development and function in larval zebrafish
- Authors
- Thompson, W.A., Shvartsburd, Z., Vijayan, M.M.
- ID
- ZDB-PUB-211203-7
- Date
- 2021
- Source
- Aquatic toxicology (Amsterdam, Netherlands) 242: 106041 (Journal)
- Registered Authors
- Vijayan, Mathilakath
- Keywords
- Cardiac performance, Heart, Municipal wastewater effluent, Serotonin, Stress response
- MeSH Terms
-
- Animals
- Antidepressive Agents/toxicity
- Embryo, Nonmammalian
- Heart
- Larva
- Venlafaxine Hydrochloride/toxicity
- Water Pollutants, Chemical*/toxicity
- Zebrafish*
- PubMed
- 34856460 Full text @ Aquat. Toxicol.
Citation
Thompson, W.A., Shvartsburd, Z., Vijayan, M.M. (2021) The antidepressant venlafaxine perturbs cardiac development and function in larval zebrafish. Aquatic toxicology (Amsterdam, Netherlands). 242:106041.
Abstract
Venlafaxine, a selective serotonin and norepinephrine reuptake inhibitor, is a highly prescribed antidepressant and is detected at µg/L concentrations in waterways receiving municipal wastewater effluents. We previously showed that early-life venlafaxine exposure disrupted the normal development of the nervous system and reduces larval activity in zebrafish (Danio rerio). However, it is unclear whether the reduced swimming activity may be associated with impaired cardiac function. Here we tested the hypothesis that zygotic exposure to venlafaxine impacts the development and function of the larval zebrafish heart. Venlafaxine (0, 1 or 10 ng) was administered by microinjection into freshly fertilized zebrafish embryos (1-4 cell stage) to assess heart development and function during early-life stages. Venlafaxine deposition in the zygote led to precocious development of the embryo heart, including the timing of the first heartbeat, increased heart size, and a higher heart rate at 24- and 48-hours post-fertilization (hpf). Also, waterborne exposure to environmental levels of this antidepressant during early development increased the heart rate at 48 hpf of zebrafish larvae mimicking the zygotic deposition. The venlafaxine-induced higher heart rate in the embryos was abolished in the presence of NAN-190, an antagonist of the 5HT1A receptor. Also, heart rate dropped below control levels in the 10 ng, but not 1 ng venlafaxine group at 72 and 96 hpf. An acute stressor reduced the venlafaxine-induced heart rate at 48 hpf but did not affect the already reduced heart rate at 72 and 96 hpf in the 10 ng venlafaxine group. Our results suggest that the higher heart rate in the venlafaxine group may be due to an enhanced serotonin stimulation of the 5HT1A receptor. Taken together, early-life venlafaxine exposure disrupts cardiac development and has the potential to compromise the cardiovascular performance of larval zebrafish.
Genes / Markers
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Orthology
Engineered Foreign Genes
Mapping